Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Conference
WCRI Issues & Research Conference 2024
The WCRI conference is a leading workers’ compensation forum.
Enlyte
Conference
Enlyte Envision 2024
Make plans to join us in Marco Island for our Customer Conference, Enlyte Envision 2024 Our Conference features t
Mitchell
Virtual Event
Top Collision Industry Trends to Watch in 2024
On-Demand
2 p.m. ET, 1 p.m. CT, 11 a.m.
Register Now
CE Webinar
Medicare Set-Aside and Workers' Compensation
On-Demand
This course will educate claims professionals on why it is important to protect Medicare’s interests and requirements for complying with the law.
Register Now
CE Webinar
Stay-at-Work/Return-to-Work Tools for Claims Handlers
On-Demand
This course will discuss the most effective tools available for claims professionals to facilitate stay-at-work/return-to-work and assist employers
Workers' Comp
White Paper
Reducing Opioid Utilization in High MED Claims
Prescription opioid overdose deaths have largely been trending downward in the past few years, with a peak in 2017.